Transfer factor in diseases of the central nervous system.
D000666:Amphotericin B / Q000627:therapeutic use; D001927:Brain Diseases / Q000276:immunology / Q000628:therapy*; D002177:Candidiasis / Q000276:immunology; D003047:Coccidioidomycosis / Q000276:immunology / Q000628:therapy; D003453:Cryptococcosis / Q000276:immunology / Q000628:therapy; D006562:Herpes Zoster / Q000628:therapy; D006801:Humans; D007111:Immunity, Cellular; D007112:Immunity, Maternally-Acquired; D007918:Leprosy / Q000628:therapy; D008213:Lymphocyte Activation; D008222:Lymphokines / Q000627:therapeutic use; D008297:Male; D008581:Meningitis / Q000628:therapy; D008875:Middle Aged; D013344:Subacute Sclerosing Panencephalitis / Q000276:immunology / Q000628:therapy; D013601:T-Lymphocytes / Q000276:immunology; D014376:Tuberculosis / Q000628:therapy; D014923:Wiskott-Aldrich Syndrome / Q000628:therapy
D008222:Lymphokines; D000666:Amphotericin B